Table 1. Target value of antibiotics usage and drug resistant organism^*.

Index	2020 (Target Value)**
Proportion of penicillin-resistance in Streptococcus pneumoniae from CSF sample	≤ 15%
Proportion of penicillin-resistance in Streptococcus pneumoniae from samples other than CSF
Proportion of fluoroquinolone resistance in Escherichia coli	≤ 25%
Proportion of methicillin resistance in Staphylococcus aureus	≤ 20%
Proportion of carbapenem resistance in Pseudomonas aeruginosa (Imipenem)	≤ 10%
Proportion of carbapenem (Meropenem) resistance in Pseudomonas aeruginosa	≤ 10%
Proportion of carbapenem (Imipenem) resistance in Escherichia coli	≤ 0.2%
Proportion of carbapenem (Meropenem) resistance in Escherichia coli	≤ 0.2%
Proportion of carbapenem (Imipenem) resistance in Klebsiella pneumoniae	≤ 0.2%
Proportion of carbapenem (Meropenem) resistance in Klebsiella pneumoniae	≤ 0.2%

^*Data extracted from Japans National Action Plan on Antimicrobial Resistance 2016-2020 (1). ^**Proportion of resistant isolates of specific indicator microorganisms in humans (%).